Test Price
800 AED✅ Home Collection Available
Factor VIII Functional Activity Test in UAE | 800 AED | 2026 DHA Guidelines
تحليل عامل التخثر الثامن (النشاط الوظيفي) في الإمارات | 800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Factor VIII Functional Activity Test
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited electromechanical clot detection.
- Premium Logistics: Paid hospital‑grade home collection with ISO‑certified cold‑chain transport; VIP mobile phlebotomy service covering all UAE emirates (8 AM–11 PM).
- Clinical Guidance: Telephonic post‑test result interpretation by a consultant hematologist (DHA‑licensed).
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 before the draw.
ملخص تنفيذي: يضمن هذا الفحص دقة تشخيصية بنسبة 99.9% باستخدام تقنية الكشف الكهروآلي المعتمدة من الهيئات التنظيمية. تشمل الخدمة السحب المنزلي المبرد وفق معايير الجودة الآيزو 9001:2015، مع استشارة هاتفية بعد النتائج وتغطية التأمين عبر التحقق المباشر عبر الواتساب.
Overview of the Factor VIII Activity Test
The Factor VIII functional activity assay quantifies the clotting ability of factor VIII, a critical protein in the intrinsic coagulation cascade. It is the gold‑standard screening tool for hemophilia A, acquired factor VIII deficiency, and monitoring of replacement therapy.
يقيس تحليل نشاط عامل التخثر الثامن وظيفة البروتين المسؤول عن تخثر الدم، ويُعد الاختبار الأساسي لتشخيص الهيموفيليا أ ونقص العامل الثامن المكتسب ومتابعة العلاج التعويضي.
| Feature | Our Test (Electromechanical Clot Detection) | Closest Alternative (Chromogenic/ELISA) |
|---|---|---|
| Precision (CV) | <3 % intra‑assay | 5–10 % |
| Methodology | Electromechanical clot endpoint – direct functional readout | Chromogenic substrate – indirect activity measurement |
| Turnaround Time | Same‑day (sample by 11 am) | 24–48 hours |
| Interference | Minimal with standard heparin/LMWH | Can be affected by color/turbidity |
Physician Insight & Safety Protocol
“Factor VIII activity must be interpreted alongside patient history, bleeding phenotype, and concurrent conditions. A single normal result does not exclude mild hemophilia, while low activity in the absence of bleeding may indicate a pre‑analytical error or an acquired inhibitor. I always recommend repeat testing and comprehensive coagulation work‑up before initiating lifelong therapy.”
— Dr. Prabhakar Reddy, Consultant Hematopathologist, DHA License 61713011
⚠ Medication Warning: Do not discontinue prescribed heparin or oral anticoagulants without explicit consent from your treating physician. Abrupt cessation can precipitate life‑threatening thrombosis.
Patient Safety: Exclusion Criteria & Emergency Red Flags
- Active severe bleeding – emergency care takes priority; test should be postponed.
- Known high‑titre factor VIII inhibitor (risk of anamnestic rise after testing).
- Inability to tolerate venipuncture or required 3 mL citrated blood draw (consult pediatric hematology for micro‑volume protocols).
- Patient on heparin or warfarin without a 1‑day (heparin) / 7‑day (warfarin) washout, unless ordered by the specialist.
- ER Red Flags: Sudden severe headache, hematuria, melena, joint swelling, or unrelenting epistaxis – go to the nearest emergency department immediately; do not wait for test results.
Pre‑Test Preparation & Specimen Collection
Patient Preparation
- Overnight fasting (8–12 h) is preferred.
- Complete mandatory Coagulation Requisition Form (Form 15).
- Discontinue heparin for 1 day and oral anticoagulants for 7 days prior, only with the treating physician’s consent.
- Avoid heavy exercise and stress immediately before collection.
Sample Collection & Transport (ISO Cold‑Chain)
- 3 mL whole blood in 1 Blue Top (3.2% Sodium Citrate) tube; mix thoroughly by inversion.
- Transport to lab within 4 hours at 2–8 °C.
- If delay >4 h, prepare platelet‑poor plasma (PPP) within 1 h: centrifuge at 3600 rpm × 15 min, transfer supernatant, repeat centrifugation, freeze immediately at -20 °C or below. Ship frozen – DO NOT THAW.
- Home collection team follows ISO‑certified cold‑chain logistics.
Patient FAQ & Clinical Guidance
Q: What is the Factor VIII activity test used for?
A: The test measures the clotting ability of factor VIII to diagnose hemophilia A, monitor replacement therapy, and detect acquired inhibitors. يقيس الاختبار قدرة عامل التخثر الثامن الوظيفية لتشخيص الهيموفيليا أ ورصد العلاج التعويضي والكشف عن المثبطات المكتسبة.
Q: How should I prepare for the?
A: Fast overnight, fill the coagulation form, and – with your doctor’s approval – stop heparin 1 day and warfarin 7 days before the draw. صم ليلة الفحص، واملأ استمارة التخثر، وبموافقة طبيبك أوقف الهيبارين لمدة يوم والوارفارين لمدة سبعة أيام قبل سحب العينة.
Q: What do the results mean?
A: A low activity (<40 %) suggests factor VIII deficiency, while a normal result does not rule out mild hemophilia – clinical correlation is essential. يدل انخفاض النشاط (أقل من 40%) على نقص العامل الثامن، أما النتيجة الطبيعية فلا تستبعد الهيموفيليا الخفيفة – والربط السريري ضروري.
UAE Regulatory Compliance: This service complies with Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (minor consent obtained via legal guardian), and UAE PDPL (Federal Decree‑Law No. 45 of 2021).
Accreditation: ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139). Laboratory License: 9834453.
Home Collection Hours: 8 AM – 11 PM daily. WhatsApp Support: +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians